EGFR and non-small cell lung carcinoma: This might also be explained by the occurrence of mutations in the EGFR gene as shown in non-small-cell lung cancer (NSCLC), where mutations in exons 18-21 coding for the tyrosine kinase domain are frequent (10-50%)[11].